pERC

pan-Canadian Pharmaceutical Alliance (pCPA): August 2019 Trends and Insights   The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the August 31, 2019 status of brand negotiations.  Highlights since the last update include: 5 products completed CADTH review, for a total of 13 files under consideration; 8 products initiated pCPA negotiations, for a total of 47 active negotiations; 7 negotiations completed for a total of 270 completed negotiations; 1 negotiation closed, for…

pan-Canadian Pharmaceutical Alliance (pCPA): July 2019 Trends and Insights   The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the status of brand negotiations as of July 31, 2019. Highlights since the last update include: 5 products completed CADTH review, for a total of 12 files under consideration; 7 products initiated pCPA negotiations, for a total of 47 active negotiations; 6 negotiations completed for a total of 263 completed negotiations; 3 negotiations…

pan-Canadian Pharmaceutical Alliance (pCPA): June 2019 Trends and Insights   The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the status of brand negotiations as of June 30, 2019. Highlights since the last update include: 6 products completed CADTH review, for a total of 15 files under consideration; 9 products initiated pCPA negotiations, for a total of 49 active negotiations; 4 negotiations completed for a total of 257 completed negotiations; 3 negotiations…

CAPCA has initiated consultations with stakeholders on its recent initiative aimed at addressing the challenges facing the oncology drug system.   The Canadian Association of Provincial Cancer Agencies (CAPCA) recently held its first set of round-table sessions (Vancouver and Toronto) with pharmaceutical industry representatives and patient groups to discuss the pan-Canadian Cancer Drug Funding Sustainability (DFS) Initiative. This initiative was initially introduced via webinars in January and February 2017 and…